Stocks / NASDAQ / Clovis Oncology, Inc.

Clovis Oncology, Inc.

Industry:   Health Care - Major Pharmaceuticals Stock Symbol:   CLVS - NASDAQ Animal Usage:   Animal Testing

Our Opinion

Clovis Oncology, Inc. is on the Cruelty Free Investing use of animals list because they use animals for drug testing and clinical trials.

Supporting Evidence:

In the following press release company mentioned the usage of animals for drug testing.

“Rubraca can cause fetal harm when administered to pregnant women based on its mechanism of action and findings from animal studies.” Read the full article.

Company Description

Clovis Oncology, Inc. is a biopharmaceutical company which focuses on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets. The company has three product candidates in its clinical development pipeline: Rociletinib, Rucaparib and Lucitani. Clovis Oncology was founded by Andrew R. Allen, Gillian C. Ivers-Read, Patrick J. Mahaffy and Erle T. Mast on April 20, 2009 and is headquartered in Boulder, CO. [Source: MarketWatch]

Company Website: http://clovisoncology.com

Contact:   http://clovisoncology.com/contact; IR: bburkart@clovisoncology.com;